Relación entre el síndrome de intestino irritable y el beneficio de los probióticos como tratamiento coadyuvante en mujeres y varones entre 15 a 50 años de edad en el Hospital Naval de Guayaquil durante el periodo de 01 de octubre de 2021 a 01 junio de 2022.

Abstract

Objective: To determine the relationship between irritable bowel syndrome and the benefit of probiotics as adjuvant treatment in women and men between 15 and 50 years of age at the Naval Hospital of Guayaquil during the period from October 1, 2021 to June 1, 2021. 2022. Methodology: the research had a type of quantitative study with a nonexperimental, retrospective and cross-sectional design whose study population was comprised of 142 patients with IBS attended by outpatients or the hospitalization area of the Naval Hospital of Guayaquil and selected through non-randomized sampling. using medical records as the main source of information. Results: Prevalence of IBS: incidence in females (98 cases / 69.00%), Ages between 15 to 23 years (43 cases / 30.3%), Etiology of environmental origin (71 cases / 50.0%), post-infectious (43 cases/ 30.3%). Frequency according to diagnostic criteria: Rome IV (86 cases/60.6%) and Rome III (53 cases/37.3%). According to evacuation pattern: Diarrhea (58 cases/ 40.8%), Constipation (57 cases/ 40.1%) and Mixed (27 cases/ 19.0%). Efficacy of probiotic treatment: Treated (52 of 71 improved) and Untreated (38 of 71 improved), bilateral significance (0.023 chi-square) – (0.015 Pearson correlation). Conclusion: The use of probiotics showed clinical efficacy compared to patients who did not receive the treatment, it is important to continue with the application of this management as a coadjuvant treatment in patients with IBS.